Interestingly, the findings from formalin fixed paraffin embedded samples were comparable to the plasma samples of invasive high grade bladder cancer patients for CDKN2A, MGMT and RASSF1A. The gene discussed is CDKN2A; the disease is urinary bladder carcinoma.